SMS Pharmaceuticals Limited (SMSPHARMA.NS) NSE

Currency In INR

AD

Valuation

Market Cap34.29B
Enterprise Value37.48B
P/E Ratio35.88
PEG Ratio0.93
Price/Sales Ratio4.29
Price/Book Ratio4.72
Enterprise/Revenue4.65
Enterprise/EBITDA23.29

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.11
Operating Margin0.15
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.14

Income Statement

Revenue8.87B
Revenue/Share97.05
Gross Profit1.75B
EBITDA1.71B
Net Income1.02B
Diluted EPS11.15

Balance Sheet

Total Cash460.75M
Total Cash/Share5.04
Total Debt3.65B
Total Debt/Equity0.46
Current Ratio1.81
Book Value Per Share85.99

Price History

52-Week Change71.18
52-Week High447.8
52-Week Low207.99
Moving Average 50 Days391.12
Moving Average 200 Days350.05

Statistics

Average Volume421,948
Shares Outstanding93.65M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield0.1
Payout Ratio0.03
Last Split Factor10:1
Last Split DateDecember 17, 2015
AD